Supernus Pharmaceuticals
SUPN
SUPN
320 hedge funds and large institutions have $3.21B invested in Supernus Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 112 increasing their positions, 120 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 312 → 320 (+8)
7% less repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 120
50% less call options, than puts
Call options by funds: $16.7M | Put options by funds: $33.2M
Holders
320
Holding in Top 10
7
Calls
$16.7M
Puts
$33.2M
Top Buyers
| 1 | +$53.5M | |
| 2 | +$48.3M | |
| 3 | +$37M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$35.3M |
| 5 |
Renaissance Technologies
New York
|
+$34.8M |
Top Sellers
| 1 | -$30.2M | |
| 2 | -$29.9M | |
| 3 | -$15.7M | |
| 4 |
Millennium Management
New York
|
-$15.6M |
| 5 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
-$13.3M |